On tuberculosis (with John Green)

On tuberculosis (with John Green)

From Drug Story by Thomas Goetz

February 17, 2026 · 45 min · Season 1 · Episode 7

About this episode

The episode discusses the impact of drug patents on tuberculosis treatment with John Green.

The idea of drug patents makes a lot of sense: The company that put the effort and resources into developing the medicine is the first to reap the benefits. That company gets a limited monopoly for 20 years, when it is the only company allowed to manufacture and sell that drug. The deal is that after that patent expires, other companies can manufacture and sell the drug, too. The drug goes “generic.” Typically that means lower prices for patients - more people benefit. That’s how the system is supposed to work. But that system relies a lot on good faith - and many pharma companies have gotten very good at finding ways to extend that 20 years, making small tweaks to a drug to extend their monopoly for years. Today, I hand Drug Story over to the excellent journalist Dan Weissmann, host of the NPR podcast An Arm and A Leg. In this episode of An Arm and a Leg, Dan talks with John Green - author of the new book, Everything is Tuberculosis. Green explains a very effective drug for TB was kept under patent protection for years, making it too expensive to treat millions of people with tuberculosis, leading to thousands of unnecessary deaths worldwide. Get full access to Drug Story at…

People in this episode

Host: Dan Weissmann

Guest: John Green

Topics covered

  • tuberculosis
  • drug patents
  • pharmaceutical industry
  • healthcare access
  • public health

Keywords

  • tuberculosis
  • drug patents
  • healthcare
  • pharmaceuticals
  • public health
  • John Green
  • Dan Weissmann

Mentioned in this episode

Organizations: NPR

Books & works: Everything is Tuberculosis

More episodes of Drug Story

Explore listener stats, chart rankings, contacts and more on the Drug Story podcast page.